Advances in the treatment of Crohn's disease and ulcerative colitis - Mayo Clinic

When used in a treat-to-target approach, therapies for mucosal healing may favorably modify the natural history of inflammatory bowel disease (IBD), reducing the need for steroids and risk of hospitalization.

Are Biologics Right for You?

Mayo Clinic on Crohn's Disease & Ulcerative Colitis: Strategies to manage IBD and take charge of your life: Farraye M.D. M.S., Francis A., Kane M.D. M.S.P.H., Sunanda V.: 9781945564086: : Books

138 Inflammatory Bowel Disease: Crohn's and Ulcerative Colitis - The Curbsiders

Ulcerative colitis - Wikipedia

Weighing the new approaches to treating Crohn's and ulcerative colitis - Harvard Health

FDA Approves Ozanimod for Ulcerative Colitis

Can molecular stratification improve the treatment of inflammatory bowel disease? - ScienceDirect

Medication and Alternative Therapies to Treat Crohn's

Etrolizumab for the Treatment of Ulcerative Colitis and Crohn's Disease: An Overview of the Phase 3 Clinical Program

Risankizumab Meets All Endpoints Vs Ustekinumab for Crohn's Disease Advances

Diagnosis and management of infections in IBD patients on immunomodulators and biologics

Ulcerative Colitis: Today, Tomorrow, and the Future - European Medical Journal

Recent advances in the treatment of IBD: Targets, mechanisms and related therapies - ScienceDirect

Innovations in Inflammatory Bowel Disease Monitoring: A Focus on Imaging and Endoscopy - Physician's Channel - Mount Sinai New York

Son los productos biológicos los indicados para usted